Minister’s comments reportedly contradict committee testimony.
Burnout has inched up year-over-year but scores are still lower than during pandemic.
Institute suggests governments pay for Canadians to seek treatment abroad.
Lack of awareness continues to hinder use of group benefit programs.
Biosimilars Canada, a national association for the biosimilar medicines industry, is drawing attention to the recent imp
Insurers are already receiving numerous claims for a new appetite-suppressing drug.
Comorbidities and the outlook for treatment and recovery examined in new note.